Last Week, bluebird bio Inc. (BLUE) Recorded A Gain Of $50.68

As of Friday close, bluebird bio Inc.’s (NASDAQ:BLUE) stock was down -$0.16, moving down -5.00 percent to $3.04. The average number of shares traded per day over the past five days has been 3,333,320 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.31 fall in that time frame. In the last twenty days, the average volume was 3,427,855, while in the previous 50 days, it was 4,491,606.

Since last month, BLUE stock retreated -12.39%. Shares of the company fell to $3.04 on 09/22/23, the lowest level in the past month. A 52-week high of $8.58 was reached on 01/13/23 after having rallying from a 52-week low of $2.78. Since the beginning of this year, BLUE’s stock price has dropped by -56.07% or -$3.88, and marked a new high 6 times. However, the stock has declined by -64.57% since its 52-week high.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything. According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.

Sponsored

BLUE stock investors should be aware that bluebird bio Inc. (BLUE) stock had its last reported insider trading activity 18 days ago on Sep 05. Klima Thomas J, the of the company, disposed of 922 shares for $3.79 on Sep 05. It resulted in a $3,493 divestment by the insider. Obenshain Andrew sold 16,929 shares at an average price of $3.54 on Aug 10. The insider now owns 291,941 shares following the transaction. On Jun 02, Klima Thomas J sold 4,130 shares at $3.50 apiece. The transaction was valued at $14,451.

Valuation Metrics

The stock’s beta is 0.92. Besides these, the trailing price-to-sales (P/S) ratio of 34.39, the price-to-book (PB) ratio of 1.14.

Financial Health

In the three months ended June 29, bluebird bio Inc.’s quick ratio stood at 2.00, while its current ratio was 2.10, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is -37.80% percent. Based on annual data, BLUE earned -$6.48 million in gross profit and brought in $3.6 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -146.30%. Return on equity (ROE) for the past 12 months was -38.40%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. BLUE’s revenue rose 77.94% to $2.38 million during the quarter, while net income inched up to $6.89 million. While analysts expected bluebird bio Inc. to report -$0.72 quarterly earnings, the actual figure was -$0.67 per share, beating the consensus estimate by 6.90%. During the quarter, the company generated -$84.33 million in EBITDA. The liabilities of bluebird bio Inc. were 374.37 million at the end of its most recent quarter ended June 29, and its total debt was $306.86 million. The value of shareholders’ equity is $106.95 million.

Technical Picture

This quick technical analysis looks at bluebird bio Inc.’s (BLUE) price momentum. With a historical volatility rate of 36.11%, the RSI 9-day stood at 27.25% on 22 September.

With respect to its five-day moving average, the current bluebird bio Inc. price is down by -9.25% percent or -$0.31. At present, BLUE shares trade -14.61% below its 20-day simple moving average and -30.43% percent below its 100-day simple moving average. However, the stock is currently trading approximately -8.16% below its SMA50 and -62.05% below its SMA200.

Stochastic coefficient K was 9.01% and Stochastic coefficient D was 7.60%, while ATR was 0.19. Given the Stochastic reading of 0.00% for the 14-day period, the RSI (14) reading has been calculated as 34.43%. As of today, the MACD Oscillator reading stands at -0.12, while the 14-day reading stands at -0.26.

Most Popular

Related Posts